We hypothesized that the lower levels of CYP26A1 expression in oral and pharyngeal cancer tissue may be due to lower RA levels, reduced retinoid signaling due to RXR phosphorylation, or an unidentified factor that may be specifically expressed in tumor tissues. Here, CYP26A1 is linked to neoplasm.